Breaking News Instant updates and real-time market news.

MYGN

Myriad Genetics

$25.55

0.34 (1.35%)

17:00
08/08/17
08/08
17:00
08/08/17
17:00

Myriad Genetics sees Q1 adjusted EPS 19c-21c, consensus 24c

Sees Q1 revenue $181M-$183M, consensus $191.85M.

  • 08

    Aug

MYGN Myriad Genetics
$25.55

0.34 (1.35%)

06/29/17
JPMS
06/29/17
NO CHANGE
Target $16
JPMS
Underweight
JPMorgan keeps Underweight rating, $16 target on Myriad Genetics
With the shares up 30% over the past month, JPMorgan analyst Tycho Peterson maintains an Underweight rating on Myriad Genetics with a $16 price target. While the company's pipeline "intriguing," it is not enough to offset a continued decline in the core hereditary cancer business, Peterson tells investors in a research note. He believes near-term catalysts could drive the stock "meaningfully higher or lower," and highlights the FY18 guidance in the Q4 earnings report as being the most significant upcoming event.
04/05/17
04/05/17
NO CHANGE

Myriad Genetics publishes pivotal studies for myPath melanoma test
Myriad Genetics has published the third clinical validation study and second clinical utility study for its myPath Melanoma test, which completes the reimbursement dossier for the product. The company will submit the reimbursement dossier to Medicare and private insurers three months earlier than expected. myPath Melanoma is an objective genetic test that measures 23 genes to help differentiate malignant melanoma from benign lesions. The third clinical validation was published in the journal Cancer Epidemiology, Biomarkers & Prevention. The study assessed the performance of the myPath Melanoma test in an independent cohort of 182 patients with melanocytic lesions against clinically proven outcomes. The results showed that the myPath Melanoma test had an overall diagnostic accuracy of 95% to effectively differentiate melanoma from benign lesions. The second clinical utility study was designed to evaluate changes in real world patient management based upon the myPath Melanoma test result. Results showed a 71% change in patient management from pre-test recommendations and an 81% reduction in biopsy site re-excisions for patients with a benign test result.
03/28/17
DBAB
03/28/17
NO CHANGE
Target $15
DBAB
Sell
Zejula label removes upside catalyst for Myriad, says Deutsche Bank
Deutsche Bank analyst Dan Leonard says FDA approval of Tesaro's (TSRO) Zejula, with a "broad rather than biomarker-limited label," removes one potential upside catalyst for Myriad Genetics (MYGN). While some investors are surprised by the broad label, many had already discounted the possibility of a label that limited usage to biomarker positive patients, which would have benefited test-supplier Myriad, Leonard tells investors in a research note. The analyst keeps a Sell rating on Myriad with a $15 price target.
03/13/17
SPHN
03/13/17
UPGRADE
SPHN
Overweight
Myriad Genetics upgraded to Overweight from Equal Weight at Stephens

TODAY'S FREE FLY STORIES

TS

Tenaris

$34.78

1.795 (5.44%)

, ABX

Barrick Gold

$11.46

0.43 (3.90%)

11:00
09/25/18
09/25
11:00
09/25/18
11:00
Recommendations
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's…

TS

Tenaris

$34.78

1.795 (5.44%)

ABX

Barrick Gold

$11.46

0.43 (3.90%)

GOLD

Randgold

$71.67

3.55 (5.21%)

INTC

Intel

$46.05

-0.86 (-1.83%)

SIRI

Sirius XM

$6.25

-0.005 (-0.08%)

P

Pandora

$9.01

0.03 (0.33%)

CGC

Canopy Growth

$54.79

2.32 (4.42%)

STZ

Constellation Brands

$215.17

-1.14 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 27

    Sep

  • 04

    Oct

  • 13

    Oct

  • 22

    Oct

  • 28

    Oct

  • 13

    Nov

GE

General Electric

$11.53

-0.215 (-1.83%)

11:00
09/25/18
09/25
11:00
09/25/18
11:00
Options
50K GE Dec 16 - Jun 12 call spreads bought for 99c »

50K GE Dec 16 - Jun 12…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

VZ

Verizon

$53.42

-0.13 (-0.24%)

10:59
09/25/18
09/25
10:59
09/25/18
10:59
Periodicals
Verizon offers early-retirement packages to 'thousands' of staff, WSJ reports »

In a move to trim its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 12

    Nov

  • 13

    Nov

VIOT

Viomi Technology

$0.00

(0.00%)

10:54
09/25/18
09/25
10:54
09/25/18
10:54
Syndicate
Breaking Syndicate news story on Viomi Technology »

Viomi Technology opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CNP

CenterPoint Energy

$27.24

-0.57 (-2.05%)

10:53
09/25/18
09/25
10:53
09/25/18
10:53
Conference/Events
CenterPoint Energy participates in a conference call with Morgan Stanley »

Group investor conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 26

    Sep

SONC

Sonic

$43.35

6.74 (18.41%)

10:52
09/25/18
09/25
10:52
09/25/18
10:52
Downgrade
Sonic rating change  »

Sonic downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BMWYY

BMW

$0.00

(0.00%)

, DDAIF

Daimler AG

$0.00

(0.00%)

10:48
09/25/18
09/25
10:48
09/25/18
10:48
Hot Stocks
BMW cuts view due to 'unexpected intense' competition following new standards »

Shares of automakers were…

BMWYY

BMW

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

GM

General Motors

$34.24

-0.5 (-1.44%)

FCAU

Fiat Chrysler

$18.13

-0.18 (-0.98%)

F

Ford

$9.52

-0.065 (-0.68%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 02

    Oct

BJ

BJ's Wholesale

$27.47

-1 (-3.51%)

10:48
09/25/18
09/25
10:48
09/25/18
10:48
Conference/Events
BJ's Wholesale participates in a conference call with William Blair »

Group investor conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 28

    Oct

  • 27

    Sep

VIOT

Viomi Technology

$0.00

(0.00%)

10:47
09/25/18
09/25
10:47
09/25/18
10:47
Syndicate
Breaking Syndicate news story on Viomi Technology »

Viomi Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

PETQ

PetIQ

$39.45

-1.62 (-3.94%)

10:46
09/25/18
09/25
10:46
09/25/18
10:46
Conference/Events
PetIQ participates in a conference call with William Blair »

Group investor conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

CVX

Chevron

$123.58

0.92 (0.75%)

10:45
09/25/18
09/25
10:45
09/25/18
10:45
Options
Chevron call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

ALDR

Alder Biopharmaceuticals

$16.88

0.125 (0.75%)

10:45
09/25/18
09/25
10:45
09/25/18
10:45
Conference/Events
Alder Biopharmaceuticals has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

TNDM

TNDM

10:42
09/25/18
09/25
10:42
09/25/18
10:42
Recommendations
TNDM analyst commentary  »

Baird not surprised by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Nov

10:40
09/25/18
09/25
10:40
09/25/18
10:40
General news
FX Action: USD-CAD »

FX Action: USD-CAD popped…

TWTR

Twitter

$28.93

0.34 (1.19%)

10:39
09/25/18
09/25
10:39
09/25/18
10:39
Hot Stocks
Twitter releases new policy to ban dehumanizing speech »

In a blog post, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 07

    Nov

VIOT

Viomi Technology

$0.00

(0.00%)

10:35
09/25/18
09/25
10:35
09/25/18
10:35
Syndicate
Breaking Syndicate news story on Viomi Technology »

Viomi Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FCAU

Fiat Chrysler

$18.22

-0.09 (-0.49%)

10:35
09/25/18
09/25
10:35
09/25/18
10:35
Options
Fiat Chrysler put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
09/25/18
09/25
10:35
09/25/18
10:35
General news
The U.S. consumer confidence »

The U.S. consumer…

CBM

Cambrex

$65.05

1.95 (3.09%)

10:31
09/25/18
09/25
10:31
09/25/18
10:31
Hot Stocks
Cambrex to expand, invest at High Point, North Carolina site »

Cambrex Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

VNTR

Venator Materials

$9.41

(0.00%)

10:25
09/25/18
09/25
10:25
09/25/18
10:25
Downgrade
Venator Materials rating change  »

Venator Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
09/25/18
09/25
10:25
09/25/18
10:25
General news
U.S. Richmond Fed manufacturing index climbed 5 points to 29 in September »

U.S. Richmond Fed…

RHHBY

Roche

$0.00

(0.00%)

10:25
09/25/18
09/25
10:25
09/25/18
10:25
Conference/Events
Roche to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 03

    Oct

10:25
09/25/18
09/25
10:25
09/25/18
10:25
Conference/Events
UBS waste market/recycling analyst to hold an analyst/industry conference call »

Analyst Windham, along…

VIOT

Viomi Technology

$0.00

(0.00%)

10:21
09/25/18
09/25
10:21
09/25/18
10:21
Syndicate
Breaking Syndicate news story on Viomi Technology »

Viomi Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FB

Facebook

$161.68

-3.72 (-2.25%)

10:20
09/25/18
09/25
10:20
09/25/18
10:20
Options
Heavy trading in Facebook as shares see relative weakness »

Heavy trading in Facebook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.